Imperial College London
Honorary Lecturer at Department of Paediatrics, St Mary's Campus.
Dr Munblit graduated from a Russian State Medical University in 2003 and then been trained at the Moscow Institute of Paediatrics and Child Surgery.
Daniel accomplished his PhD research at Imperial College London in 2016. Prior to this he successfully completed MSc in Allergy programme at Imperial College London.
His main research focus is the primary prevention of allergic disease in childhood. Investigation of human colostrum and mature breast milk immune-modulatory factors in relation to maternal health, nutrition and genotype and subsequent infant outcomes in relation to susceptibility to allergy. Later he has developed a strong interest in systematic evaluation of available evidence.
Dr. Munblit coordinated EU Horizon 2020 application (BIRTH project) in 2014. This project aimed to develop standards for human milk analysis, identify maternal genetic and environmental factors that modify milk composition, systematically review existing evidence on human milk research and conduct intervention trials in mothers aiming to modify human milk composition andthereby promote improved health outcomes in the child.
Daniel leads The Core Outcome Measures for Food Allergy (COMFA) COST Action, approved by the EU commissioners in June 2019. This project is aiming to define the scope and applicability of food allergy Core Outcome sets and develop Core Outcome sets and measurement tools for food allergy.
Dr. Munblit is a member of the European Academy of Allergy and Clinical Immunology (EAACI) Pediatric section board. He is also a member of Paediatric Allergy Education & Training Committee (PA-ETC) at EAACI and a member of Education & Training Committee at World Allergy Organization (WAO).
Apart from research activities, Daniel is lecturing at MSc in Paediatrics and MSc in Allergy courses and supervising students at Imperial College London and Sechenov University, Moscow, Russia.